Vise Technologies, Inc. Dynavax Technologies Corp Transaction History
Vise Technologies, Inc.
- $2.32 Billion
- Q2 2025
A detailed history of Vise Technologies, Inc. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Vise Technologies, Inc. holds 23,309 shares of DVAX stock, worth $234,721. This represents 0.01% of its overall portfolio holdings.
Number of Shares
23,309Holding current value
$234,721% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding DVAX
# of Institutions
294Shares Held
120MCall Options Held
294KPut Options Held
77.6K-
Black Rock Inc. New York, NY21.9MShares$221 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$179 Million6.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$84.9 Million0.0% of portfolio
-
State Street Corp Boston, MA6.4MShares$64.4 Million0.0% of portfolio
-
Chicago Capital, LLC4.31MShares$43.4 Million1.06% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.27B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...